Aspen Aerogels (NYSE: ASPN) reported Q2 EPS of ($0.22), $0.15 better than the analyst estimate of ($0.37). Revenue for the quarter came in at $48.2 million versus the consensus estimate of $48.81 million.

GUIDANCE:

Aspen Aerogels sees FY2023 revenue of $200-250 million, versus the consensus of $225.7 million.

For earnings history and earnings-related data on Aspen Aerogels (ASPN) click here.